Singapore markets closed

SAB Biotherapeutics, Inc. (SABSW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.0324+0.0024 (+8.00%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
56,566
15,047
33,207
12,610
Total cash
56,566
15,047
33,207
12,610
Net receivables
0
5,557
8,011
20,569
Other current assets
2,341
1,494
-
-
Total current assets
58,907
22,097
50,192
34,455
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
34,596
34,618
34,169
23,850
Accumulated depreciation
-9,912
-6,279
-3,220
-1,767
Net property, plant and equipment
24,684
28,340
30,949
22,083
Total non-current assets
25,034
28,807
30,949
22,083
Total assets
83,941
50,905
81,141
56,538
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
1,051
772.665
1,797
538.731
Accounts payable
945.927
3,679
4,459
7,382
Accrued liabilities
2,204
3,495
4,783
1,466
Deferred revenues
1,322
0
100
100
Other current liabilities
-
-
6,338
-
Total current liabilities
10,813
14,993
26,455
11,062
Non-current liabilities
Long-term debt
-
541.644
-
172.037
Total non-current liabilities
15,828
4,853
16,136
6,468
Total liabilities
26,642
19,847
42,591
17,530
Stockholders' equity
Common stock
0.934
0.51
4.349
2.598
Retained earnings
-90,064
-47,870
-29,129
-11,984
Accumulated other comprehensive income
26.42
0
-
-
Total stockholders' equity
57,299
31,058
38,550
39,008
Total liabilities and stockholders' equity
83,941
50,905
81,141
56,538